NCT00443846
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +15 more
- Locations
-
Not specified
Clinical trial condition
Neisseriaceae Infections
Explore clinical trials studying Neisseriaceae Infections. Study availability and eligibility vary by location and protocol.
400 public trials
21 recruiting studies
Neisseriaceae Infections trial results
NCT01345721
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- Dr. Johannes Kandzora and Dr. Kathrin Kandzora Am Teich 11, Neumuenster, Germany
- Bogda-Maria Kniese, Boyneburgstr 7, Eschwege, Germany
- Dr Goertz Martin Kimmig GroBbottwarer Str 47, Oberstenfeld, Germany
- Dr med Walter Otto Heinrichstrasse 16 A, Fulda, Germany
NCT01148524
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
- Locations
-
- Centro de Salud Lo Barnechea Santiago, Chile
- Centro para vacunas en desarrollo. Hospital de Niños Roberto del Río Santiago, Chile
- Escuela de Medicina de la Universidad de Valparaíso Santiago, Chile
- Hospital Luis Calvo Mackenna Santiago, Chile
Completed
Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects
NCT00464815
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Goā, India
- GSK Investigational Site Indore, India
- GSK Investigational Site New Delhi, India
- GSK Investigational Site Pune, India
NCT00454909
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Daly City, California, United States
- GSK Investigational Site Fairfield, California, United States
- GSK Investigational Site Redwood City, California, United States
- GSK Investigational Site Sacramento, California, United States
NCT00465816
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Aarhus N, Denmark
- GSK Investigational Site Karlskrona, Sweden
- GSK Investigational Site Linköping, Sweden
- GSK Investigational Site Malmö, Sweden
NCT00290329
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Alabang, Muntinlupa City, Philippines
- GSK Investigational Site Binangonan, Rizal, Philippines
- GSK Investigational Site Cainta, Rizal, Philippines
- GSK Investigational Site City of Muntinlupa, Philippines
NCT00196976
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Eferding, Austria
- GSK Investigational Site Graz, Austria
- GSK Investigational Site Salzburg, Austria
- GSK Investigational Site Vienna, Austria
Completed
Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects
NCT00317109
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
- Locations
-
- GSK Investigational Site Brits, South Africa
- GSK Investigational Site Ga-Rankuwa, South Africa
- GSK Investigational Site Rooihuiskraal, South Africa
NCT00291343
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
- Locations
-
- GSK Investigational Site Manila, Philippines
- GSK Investigational Site Sampaloc, Manila, Philippines